Carole Le Pogam

BCL-2 and Mutant NRAS Interact Physically and Functionally in a Mouse Model of Progressive Myelodysplasia

Nader Omidvar, Scott C. Kogan, Stéphanie Beurlet et al. · Cancer Research · 2007 · 58 citations · Full text

BCL-2 inhibition with ABT-737 prolongs survival in an NRAS/BCL-2 mouse model of AML by targeting primitive LSK and progenitor cells

Stéphanie Beurlet, Nader Omidvar, Petra Gorombei et al. · Blood · 2013 · 48 citations · Full text

DNA vaccination with all-trans retinoic acid treatment induces long-term survival and elicits specific immune responses requiring CD4+ and CD8+ T-cell activation in an acute promyelocytic leukemia mouse model

Kouichi Furugaki, Kateřina Pokorná, Carole Le Pogam et al. · Blood · 2009 · 27 citations · Full text

BCL-2 Inhibitor ABT-737 Effectively Targets Leukemia-Initiating Cells with Differential Regulation of Relevant Genes Leading to Extended Survival in a NRAS/BCL-2 Mouse Model of High Risk-Myelodysplastic Syndrome

Petra Gorombei, Fabien Guidez, Saravanan Ganesan et al. · International Journal of Molecular Sciences · 2021 · 17 citations · Full text

Mixed-phenotype Acute Leukemia, Immunology, Extended Survival +19

GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways

Laura Guerenne, Stéphanie Beurlet, M.S. Said et al. · Journal of Hematology & Oncology · 2016 · 13 citations · Full text